The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2018 | Shifting the focus in CLL: the epigenome
Research into the underlying pathology of chronic lymphocytic leukemia (CLL) most often focuses on the genetic changes; however, it is becoming apparent that the epigenome plays a large role in leukemogenesis. Here, Iñaki Martín-Subero, PhD, of the Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain, discusses the aberrant epigenetic changes underlying CLL. This video was recorded at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.
